Valor pronóstico de la fracción alélica mutada (MAF) en el paciente con cáncer colorrectal

22 / 25

Independent dataset CAPRI-GOIM trial
(2nd line)
33 pts RAS mut in
plasma
340 pts in CAPRI-GOIM
trial
92 pts with baseline
plasma sample
32 pts RAS mut in
plasma
1 pt with lack follow-up
data